FairJourney Biologics
Pedro Gomes is a Senior Scientist at FairJourney Biologics since February 2023 and has held multiple academic positions at the Faculty of Medicine, Porto University, including Invited Assistant Professor, Assistant Researcher, Volunteer Assistant Professor, and Postdoctoral Scientist since January 2007. Previous experience includes postdoctoral roles at the Center for Neuroscience and Cell Biology and the ICVS - Life and Health Sciences Research Institute, along with a postdoctoral fellowship at the David Geffen School of Medicine at UCLA. Pedro Gomes obtained a PhD in Human Biology from Universidade do Porto and a Licentiate degree in Biological Engineering from Escola de Engenharia da Universidade do Minho, alongside postdoctoral studies at the ICVS and UCLA.
FairJourney Biologics
FairJourney Biologics is a privately established company with an outstanding track record of biotech and biopharmaceutical partners (Merus, argenX, BMS, Bayer, among others), offering a range of assets and services on antibody discovery, engineering, production, characterization up to cell line development stages. Our naïve and immune libraries from humans, rodents and llama, together with our know-how and internal technological development allow us to contribute to the pipeline of our partners on complex targets, leading to 14 known antibodies in the clinic. More recently, FairJourney Biologics has been joined by specialists in the field such as Tariq Ghayur (formerly Abbvie) and Rene Hoet (formerly Bayer), creating a panel of available scientists as service to support complex antibody projects. From target validation up to cell line development and pre-CMC reporting, FairJourney Biologics is a one stop shop leader in antibody services. As of 2022, the company has a headcount of above 200 staff members and a track record of more than 800 projects on a variety of areas.